What question did this study set out to answer?

To investigate sphingolipid and phospholipid levels in patients with XK disease and their potential role in neurodegeneration.

February 26, 20260 citations

View Full Paper

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

GMGabriel Miltenberger-MiltenyiUniversity of Lisbon VCVasco A. ConceiçãoUniversity of Lisbon KLKlaudia LaborcAllen Institute for Brain Science

Key Points

To investigate sphingolipid and phospholipid levels in patients with XK disease and their potential role in neurodegeneration.
Analyzed brain lipid concentrations in XK disease patients.
Compared levels of sphingolipids and phospholipids to control subjects.
Identified abnormal sphingolipid concentrations in XK patients.
Suggested links between altered lipid levels and neurodegeneration.

Abstract

Our findings provide initial evidence of abnormal sphingolipid and phospholipid concentrations in the brains of XK patients and may provide insights into mechanisms of neurodegeneration in this disease. © 2026 International Parkinson and Movement Disorder Society.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider